Class 2 Device Recall 550 TxT Treatment Tables which are used in PRIMUS, ONCOR, ARTISTE Linac systems

• Date Initiated by Firm: December 05, 2013
• Date Posted: January 17, 2014
• Recall Status: Terminated on January 30, 2015
• Recall Number: Z-0787-2014
• Recall Event ID: 67126
• 510(K)Number: K050422
• Product Classification: Couch, radiation therapy, powered - Product Code JAI
• Product: PRIMUS, ONCOR, ARTISTE Linac systems with component 550 TxT Treatment Table.; TT-A, TT-D, TT-M or TT-S Table tops.; ; Manufactured by:; SIEMENS AG, MEDICAL SOLUTIONS ; Roentgenstrasse 19-21 ; Kemnath, GERMANY 95478 ; ; The intended use of the SIEMENS branded, ARTISTE", ONCOR" and PRIMUS" family of linear accelerator systems is to deliver X-ray photon and electron radiation for the therapeutic treatment of cancer.
• Code Information: 550 TxT table - part number 07346534.
• Recalling Firm/ Manufacturer: Siemens Medical Solutions USA, Inc; 757 Arnold Dr Ste A; Martinez CA 94553-3615
• For Additional Information Contact: Christine Dunbar; 925-293-5442
• Manufacturer Reason for Recall: Update to correct the possibility for patients or operators to have their fingers trapped or pinched between the table top and the bottom frame of the 550 TxT Treatment Table. Combined with this update instruction is a second complaint issue related to an incident in which a cable inside of the TxT" Treatment Table has been damaged due to contacting a moving part. The resulting short-circuit cau
• FDA Determined Cause: Device Design
• Action: The firm, Siemens, sent a "Medical Device Correction" letter to affected users/customers starting on December 5, 2013 via Federal express. The letter described the product, problem and actions to be taken. Siemens has arranged for modification of the affected 500 TxT Treatment Table. A service representative will modify the mounts of the TT-A, TT-D, TT-M, or TT-s table tops ( Pleases note that this modification only applies to the Siemens provided table tops TT-A, TT-D, TT-M, and TT-S.). In addition, the Siemens service representative will modify the cable routing inside of the patient table base. The customers were instructed to include this Field Safety Notice in your Digital Linear Accelerator System Owner manual chapter 'Safety Advisory Letters' where it should remain. If you have any questions, please contact the Senior Manager, Regulatory Affairs at 1-925-293-5442 or email: christine.dunbar@siemens.com.
• Quantity in Commerce: 305 active devices.
• Distribution: Worldwide Distribution: US (nationwide) and internationally to: Canada, Italy, P.R. China, Argentina, Pakistan, South Africa, Egypt, Iran, Vietnam, Indonesia, Brazil, Hungary, Bulgaria, India, Spain, Switzerland, Trinidad, Tobago, Italy, Algeria, Croatia, Turkey, Japan, Germany, Portugal, Poland, France, Sri Lanka, Russian Federation, France, Lebanon, Slovakia, Ukraine, Pakistan, and Korean Republic.
• Total Product Life Cycle: TPLC Device Report

¹ A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
² Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
³ For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.

• 510(K) Database: 510(K)s with Product Code = JAI and Original Applicant = SIEMENS MEDICAL SOLUTIONS USA, INC.